Skip to main content
Top
Published in: European Journal of Pediatrics 1/2018

Open Access 01-01-2018 | Original Article

Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data

Authors: Yan Xing, Hua Zhang, Shusen Sun, Xiang Ma, Roy A. Pleasants, Huilin Tang, Hangci Zheng, Suodi Zhai, Tiansheng Wang

Published in: European Journal of Pediatrics | Issue 1/2018

Login to get access

Abstract

We assessed the clinical features and treatment of pediatric patients with drug-induced anaphylaxis in clinical settings. Pediatric drug-induced anaphylaxis cases collected by the Beijing Pharmacovigilance Database from 2004 to 2014 were analyzed. A total of 91 cases were identified. Drug-induced anaphylaxis was primarily caused by antibiotics (53%). Children of 0–5 years were more likely to develop cyanosis symptoms than children of 13–17 years (OR = 5.14, 95%CI [1.74, 15.20], P = 0.002). Children of 13–17 years were more likely to develop hypotension than children of 6–12 years (OR = 11.79, 95%CI [2.28, 60.87], P = 0.002), and to manifest both neurological symptoms (OR = 3.56, 95%CI [1.26, 10.08], P = 0.015) and severe anaphylaxis than children of 0–5 years (OR = 15.46, 95%CI [1.85, 129.33], P = 0.002). Supratherapeutic doses of epinephrine were more likely with intravenous (IV) bolus (92%) in contrast to either intramuscular (IM) (36%, OR = 19.25, 95%CI [1.77, 209.55], P = 0.009) or subcutaneous (SC) injections (36%, OR = 19.80, 95% CI [1.94, 201.63], P = 0.005). Only 62 (68%) patients received epinephrine treatment as the first-line therapy.
Conclusion: This study demonstrates that antibiotics were the most common cause of pediatric drug-induced anaphylaxis. Children may present with different anaphylactic signs/symptoms based on age groups. Epinephrine is under-utilized and provider education on the proper management of drug-induced anaphylaxis is warranted.
What is Known:
The most common causes of anaphylaxis in children are allergies to foods. Drugs are the second most common cause of pediatric anaphylaxis.
• IM epinephrine is the recommended initial treatment of anaphylaxis.
What is New:
Drug-induced anaphylaxis in pediatric patients has age-related clinical features.
• IV bolus epinephrine was overused and associated with supratherapeutic dosing.
Appendix
Available only for authorised users
Literature
4.
5.
go back to reference Cao HS, He PB, Yang LZ (2006) Analysis of 288 anaphylaxis cases induced by herb injections. Chin J Pharmacoepidemiol (15):26–27 Cao HS, He PB, Yang LZ (2006) Analysis of 288 anaphylaxis cases induced by herb injections. Chin J Pharmacoepidemiol (15):26–27
6.
go back to reference Dona I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, Garcia-Nunez I, Gomez F, Salas M, Rondon C, Canto MG, Blanca M (2012) Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 22(5):363–371PubMed Dona I, Blanca-Lopez N, Torres MJ, Garcia-Campos J, Garcia-Nunez I, Gomez F, Salas M, Rondon C, Canto MG, Blanca M (2012) Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients. J Investig Allergol Clin Immunol 22(5):363–371PubMed
10.
go back to reference Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T, Rueff F, Nemat K, Maris I, Roumpedaki E, Scherer K, Ott H, Reese T, Mustakov T, Lang R, Fernandez-Rivas M, Kowalski ML, Bilo MB, Hourihane JO, Papadopoulos NG, Beyer K, Muraro A, Worm M (2016) Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol 137(4):1128–1137. https://doi.org/10.1016/j.jaci.2015.11.015 CrossRefPubMed Grabenhenrich LB, Dolle S, Moneret-Vautrin A, Kohli A, Lange L, Spindler T, Rueff F, Nemat K, Maris I, Roumpedaki E, Scherer K, Ott H, Reese T, Mustakov T, Lang R, Fernandez-Rivas M, Kowalski ML, Bilo MB, Hourihane JO, Papadopoulos NG, Beyer K, Muraro A, Worm M (2016) Anaphylaxis in children and adolescents: the European Anaphylaxis Registry. J Allergy Clin Immunol 137(4):1128–1137. https://​doi.​org/​10.​1016/​j.​jaci.​2015.​11.​015 CrossRefPubMed
13.
go back to reference Hsin YC, Hsin YC, Huang JL, Yeh KW (2011) Clinical features of adult and pediatric anaphylaxis in Taiwan. Asian Pac J Allergy Immunol 29(4):307–312PubMed Hsin YC, Hsin YC, Huang JL, Yeh KW (2011) Clinical features of adult and pediatric anaphylaxis in Taiwan. Asian Pac J Allergy Immunol 29(4):307–312PubMed
14.
go back to reference Jackson KD, Howie LD, Akinbami LJ (2013) Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief 121:1–8 Jackson KD, Howie LD, Akinbami LJ (2013) Trends in allergic conditions among children: United States, 1997–2011. NCHS Data Brief 121:1–8
19.
go back to reference Manuyakorn W, Benjaponpitak S, Kamchaisatian W, Vilaiyuk S, Sasisakulporn C, Jotikasthira W (2015) Pediatric anaphylaxis: triggers, clinical features, and treatment in a tertiary-care hospital. Asian Pac J Allergy Immunol 33(4):281–288. 10.12932/AP0610.33.4.2015 PubMed Manuyakorn W, Benjaponpitak S, Kamchaisatian W, Vilaiyuk S, Sasisakulporn C, Jotikasthira W (2015) Pediatric anaphylaxis: triggers, clinical features, and treatment in a tertiary-care hospital. Asian Pac J Allergy Immunol 33(4):281–288. 10.​12932/​AP0610.​33.​4.​2015 PubMed
21.
go back to reference Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez RM, Santos AF, Zolkipli ZQ, Bellou A, Beyer K, Bindslev-Jensen C, Cardona V, Clark AT, Demoly P, Dubois AE, DunnGalvin A, Eigenmann P, Halken S, Harada L, Lack G, Jutel M, Niggemann B, Rueff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S, Akdis CA, Sheikh A (2014) Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 69(8):1026–1045. https://doi.org/10.1111/all.12437 CrossRefPubMed Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez RM, Santos AF, Zolkipli ZQ, Bellou A, Beyer K, Bindslev-Jensen C, Cardona V, Clark AT, Demoly P, Dubois AE, DunnGalvin A, Eigenmann P, Halken S, Harada L, Lack G, Jutel M, Niggemann B, Rueff F, Timmermans F, Vlieg-Boerstra BJ, Werfel T, Dhami S, Panesar S, Akdis CA, Sheikh A (2014) Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 69(8):1026–1045. https://​doi.​org/​10.​1111/​all.​12437 CrossRefPubMed
22.
go back to reference National Cooperative Group on Childhood Asthma (2013) Third nationwide survey of childhood asthma in urban areas of China. Chin J Pediatr 51(10):729–735 National Cooperative Group on Childhood Asthma (2013) Third nationwide survey of childhood asthma in urban areas of China. Chin J Pediatr 51(10):729–735
25.
go back to reference Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NJ, Bock SA, Branum A, Brown SG, Camargo CJ, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AJ, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report—second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117(2):391–397. https://doi.org/10.1016/j.jaci.2005.12.1303 CrossRefPubMed Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NJ, Bock SA, Branum A, Brown SG, Camargo CJ, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AJ, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R, Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW (2006) Second symposium on the definition and management of anaphylaxis: summary report—second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117(2):391–397. https://​doi.​org/​10.​1016/​j.​jaci.​2005.​12.​1303 CrossRefPubMed
33.
go back to reference Wiener ES, Bajaj L (2005) Diagnosis and emergent management of anaphylaxis in children. Adv Pediatr Infect Dis 52:195–206 Wiener ES, Bajaj L (2005) Diagnosis and emergent management of anaphylaxis in children. Adv Pediatr Infect Dis 52:195–206
Metadata
Title
Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: a study based on pharmacovigilance data
Authors
Yan Xing
Hua Zhang
Shusen Sun
Xiang Ma
Roy A. Pleasants
Huilin Tang
Hangci Zheng
Suodi Zhai
Tiansheng Wang
Publication date
01-01-2018
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Pediatrics / Issue 1/2018
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-017-3048-z

Other articles of this Issue 1/2018

European Journal of Pediatrics 1/2018 Go to the issue